Mankind Pharma Ltd (MANKIND)
₹1742.55
Overview of Mankind Pharma Ltd
Key events for Mankind Pharma Ltd
Mankind Pharma Commences Commercial Operations at New Plant in Rajasthan - 25 Sep, 2023
Mankind Pharma Ltd has started commercial operations for pharmaceutical formulations at its new plant in Udaipur, Rajasthan.
Mankind Pharma's IPO Sees Stock Soar 32% - 22 Sep, 2023
Mankind Pharma, India's leading condom maker with a 33% market share, conducted a $520 million IPO in May and saw its stock soar 32% on debut, valuing the company at $7 billion.
Mankind Pharma Soars on Market Debut After Successful IPO - 21 Sep, 2023
Mankind Pharma Ltd's successful $520 million IPO in May led to a 32% surge in stock prices on its market debut, resulting in a valuation of $7 billion.
Mankind Pharma IPO to Open Next Week - 15 Sep, 2023
Mankind Pharma Ltd is set to launch its initial public offering (IPO) next week. Details on the price band and grey market premium are yet to be announced.
Mankind Pharma Reports Highest Growth in August - 13 Sep, 2023
According to the All India Organisation of Chemists and Druggists, Mankind Pharma Ltd. reported the highest growth in August at 10%.
Mankind Pharma Among Top Stocks to Watch Today - 04 Sep, 2023
No specific news related to Mankind Pharma Ltd. However, the company is among the top stocks to watch today.
Lock-In Release for Majority Stake in Mankind Pharma - 28 Aug, 2023
Around 280 million shares, or 70% of Mankind Pharma's stake, will be released from lock-in on November 06. The company had the largest IPO in the pharma sector earlier this year.
Mankind Pharma to Incorporate Wholly Owned Subsidiary - 25 Aug, 2023
Mankind Pharma Ltd's board has approved the incorporation of a wholly owned subsidiary, Mankind Medicare, with an authorized capital of Rs 5 crore. The subsidiary will manufacture pharmaceutical dosage forms and consumer healthcare products.
Investor Impressed with Mankind Pharma - 24 Aug, 2023
An investor expresses interest in finding the right entry point for Mankind Pharma Ltd.
Mankind Pharma Outperforms Indian Pharma Market - 22 Aug, 2023
Mankind Pharma, with 97% of revenue from India alone, consistently outperformed the sales growth of the overall Indian pharma market. The management is betting on chronic therapies to drive next leg of growth.
Mankind Pharma Stock Rises Despite Market Share Loss - 14 Aug, 2023
Despite losing maximum market share in the Indian pharma market over the past six months, Mankind Pharma's stock rose to Rs 1,834.4 apiece.
Mankind Pharma Achieves 20 SMA of Rs 1837.4 - 11 Aug, 2023
On August 10, Mankind Pharma achieved a 20-day Simple Moving Average (SMA) of Rs 1837.4 and closed at Rs 1841.6 on the same day.
Mankind Pharma Shares Rise Despite Recent Losses - 09 Aug, 2023
Mankind Pharma Ltd's shares rose by 0.59% following strong Q1 results, despite a recent loss of 2.27%. The company's RSI has dropped to 49.24.
Mankind Pharma's Stock Continues Uptrend - 04 Aug, 2023
Mankind Pharma Ltd's stock continues to rise with the company's recent IPO rallying 61%, and the RSI rising above 60 indicating a potential continuation of the uptrend.
Mankind Pharma Reports Strong Q1FY24 Results - 03 Aug, 2023
Mankind Pharma Ltd reported a sharp increase in Q1FY24 net profit and revenue, driven by strong domestic sales and industry-beating growth from its pharma segment.
Mankind Pharma Reports Strong Q1 Results - 02 Aug, 2023
Mankind Pharma's Q1FY24 results show strong double-digit growth in sales and profitability, with pharma segment outperforming IPM by 1.5x. Shares close 1.81% lower.
Mankind Pharma to Announce Q1 Results - 01 Aug, 2023
Mankind Pharma Ltd will be in focus as it is set to announce its June quarter results.
Mankind Pharma Upgraded to Large Caps; Restructures Portfolio - 31 Jul, 2023
Mankind Pharma Ltd has been upgraded from mid to large caps and has restructured its portfolio in favor of mid-cap stocks.
Mankind Pharma Discontinues Cough Syrup and Has Biggest IPO This Year - 20 Jul, 2023
Mankind Pharma discontinues its cough syrup Tedykoff since February. The company also had the biggest public issue this year with an IPO size of Rs 4,326 crore.
Mankind Pharma's Strong Debut on the Stock Market - 19 Jul, 2023
Mankind Pharma had a strong debut on the stock market, listing at a premium of 15% over its issue price. It was the only public offer in 2023 with an issue size of over Rs 1,000 crore.
Analyst Rating
based on 10 analysts
Based on 10 analysts offering long term price targets for Mankind Pharma Ltd. An average target of ₹1837.8
Source: S&P Global Market Intelligence
Mankind Pharma Ltd Performance
- ₹1721.55₹1759.9₹1742.55
1.21%
Downside
Day's Volatility:2.20%
Upside
1.00%
- ₹1242₹1949₹1742.55
28.73%
Downside
52 Weeks Volatility:40.57%
Upside
11.85%
| Returns % | |
| 1 Month Return | -1.2 % |
| 3 Month Return | 2.87 % |
| 1 Year Return | 23.17 % |
| Market Stats | |
| Previous Close | ₹1,751.80 |
| Open | ₹1,759.90 |
| Volume | 78.96K |
| Market Cap | ₹70,175.08Cr |
Mankind Pharma Ltd Company Information
Share Price: ₹1742.55 per share as on 25 Sep, 2023 04:01 PM
Market Capitalisation: ₹70,175.08Cr as of today
Revenue: ₹2,102.95Cr as on March 2023 (Q1 23)
Net Profit: ₹285.44Cr as on March 2023 (Q1 23)
Listing date: 09 May, 2023
| Organisation | Mankind Pharma Ltd |
| Headquarters | New Delhi |
| Industry | Trading |
| E-voting on shares | Click here to vote |
Fundamentals of Mankind Pharma Ltd
Insights on Mankind Pharma Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTFII Holding Up
Foreign Institutions have increased holdings from 2.61% to 4.18% in Jun 2023 quarter
- POSITIVE IMPACT
MF Holding Up
Mutual Funds have increased holdings from 1.83% to 3.92% in Jun 2023 quarter
NO EFFECTPromoter Holding Unchanged
Promoters holdings remained unchanged at 76.50% of holdings in Jun 2023 quarter
NEGATIVE IMPACTRetail Holding Down
Retail Investor have decreased holdings from 18.25% to 14.68% in Jun 2023 quarter
- NEGATIVE IMPACT
Price Dip
In the last 1 month, MANKIND stock has moved down by -1.9%
Mankind Pharma Ltd Valuation
Mankind Pharma Ltd in the last 5 years
Lowest (41.33x)
May 24, 2023
Today (47.54x)
September 22, 2023
Industry (50.40x)
September 22, 2023
Highest (54.59x)
June 20, 2023
Mutual Fund Holdings
| Funds | Holdings |
 Axis Long Term Equity Fund Direct Plan Growth Option | 1% |
 SBI Bluechip Fund Direct Growth | 0.67% |
| SBI Magnum Midcap Fund Direct Growth | 1.61% |
 Nippon India Pharma Fund - Direct Plan - Growth Plan | 3.19% |
 Motilal Oswal Long Term Equity Fund Direct Plan Growth | 5.05% |
Mankind Pharma Ltd Shareholding Pattern
| Investors | Holdings % | Prev. 3 periods | 3M change |
|---|---|---|---|
| Promoter Holdings | 76.5% | 0.00 | |
| Foreign Institutions | 4.18% | 60.15 | |
| Mutual Funds | 3.92% | 114.00 | |
| Retail Investors | 14.68% | ||
| Others | 0.72% |
Technicals of Mankind Pharma Ltd
News & Events of Mankind Pharma Ltd
Frequently Asked Questions
Mankind Pharma Ltd (MANKIND) share price today is ₹1742.55
- Today’s highest price of Mankind Pharma Ltd is ₹1759.9.
- Today’s lowest price of Mankind Pharma Ltd is ₹1721.55.
Today’s traded volume of Mankind Pharma Ltd(MANKIND) is 78.96K.
Today’s market capitalisation of Mankind Pharma Ltd(MANKIND) is ₹70175.08Cr.
| Mankind Pharma Ltd(MANKIND | Price |
|---|---|
52 Week High | ₹1949 |
52 Week Low | ₹1242 |
Mankind Pharma Ltd(MANKIND) share price is ₹1742.55. It is down -10.59% from its 52 Week High price of ₹1949
Mankind Pharma Ltd(MANKIND) share price is ₹1742.55. It is up 40.30% from its 52 Week Low price of ₹1242
| Mankind Pharma Ltd(MANKIND | Returns |
|---|---|
1 Day Returns | -9.25% |
1 Month Returns | -1.2% |
3 Month Returns | 2.87% |
1 Year Returns | 23.17% |